Primecap Management’s Calithera Biosciences, Inc CALA Stock Holding History

Primecap Management’s Portfolio CALA Stock Details CALA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-401,080	Closed	-$1.31M	–	342
2022 Q4	$1.31M	Sell	401,080 -13,400	-3%	-$32K	﹤0.01%	308
2022 Q3	$1.22M	Sell	414,480 -5,800	-1%	-$19.8K	﹤0.01%	311
2022 Q2	$1.03M	Sell	420,280 -116,370	-22%	-$539K	﹤0.01%	319
2022 Q1	$4.34M	Hold	536,650	–	–	﹤0.01%	290
2021 Q4	$7.14M	Buy	536,650 +6,215	+1%	+$156K	﹤0.01%	284
2021 Q3	$23.1M	Buy	530,435 +13,250	+3%	+$572K	0.02%	235
2021 Q2	$21.6M	Buy	517,185 +500	+0.1%	+$22K	0.01%	239
2021 Q1	$25M	Buy	516,685 +4,010	+0.8%	+$233K	0.02%	230
2020 Q4	$50.3M	Buy	512,675 +9,600	+2%	+$841K	0.04%	189
2020 Q3	$34.7M	Sell	503,075 -315	-0.1%	-$27.5K	0.03%	188
2020 Q2	$53.2M	Buy	503,390 +30,585	+6%	+$3.63M	0.05%	169
2020 Q1	$42M	Sell	472,805 -1,595	-0.3%	-$190K	0.04%	165
2019 Q4	$54.2M	Buy	+474,400	New	+$35.7M	0.04%	170

Other funds holding CALA

FCA

FinTrust Capital Advisors Greenville, South Carolina $591M AUM 26.89% 1-Year Est. Return

Primecap Management's CALA Position: Q1 2023 in Review

Primecap Management sold out of Calithera Biosciences, Inc (CALA) in Q1 2023, closing a stake of 401,080 shares — an estimated $1.31M sold.

Primecap Management first reported a position in CALA in Q4 2019 and held it in 13 quarters. The position peaked at $54.2M in Q4 2019. 2 funds tracked by Wall St. Rank hold CALA as of Q1 2023.

Primecap Management reported no remaining Calithera Biosciences, Inc position as of Q1 2023 after selling out during the quarter.
Primecap Management sold 401,080 Calithera Biosciences, Inc shares in Q1 2023, an estimated $1.31M.
Primecap Management first reported a position in Calithera Biosciences, Inc in Q4 2019 and held it in 13 quarters.
Primecap Management's Calithera Biosciences, Inc position peaked at $54.2M in Q4 2019.
2 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q1 2023.

Based on Primecap Management's 13F filing for Q1 2023, filed 15 May 2023.